Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02785302 · ClinicalTrials.gov registry record

Transitioning HIV+ Adolescents to Adult Care: Exploring Adolescent and Adult Medicine Clinics Role in the Process

A clinical trial of HIV, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
136
Enrollment target
14
Study locations

NCT02785302: Completed study of HIV, sponsored by University of North Carolina, Chapel Hill.

NCT02785302 is a study of HIV that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 136 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (69% lower). The trial reports 14 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02785302, a study of HIV, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
136 participants
Enrollment target
14
Study locations

Study Summary

This is a multi-site, longitudinal study and it describes the transition process of behaviorally-infected HIV-positive youth as they move from pediatric- and adolescent-specific care to adult care. To achieve this goal, the transition process is characterized from the perspectives of HIV-positive youth, Adolescent Medicine Trials Unit (AMTU) clinic staff, and receiving adult clinic staff.

Conditions Studied

Study Locations (14)

Florida

  • University of Miami - Miami
  • University of South Florida - Tampa

California

  • Childrens Hospital of Los Angeles - Los Angeles

Colorado

  • University of Colorado - The Children's Hospital of Denver - Aurora

District of Columbia

  • Children's Hosp Natinal Med Center - Washington D.C.

Illinois

  • Stroger Hospital of Cook County - Chicago

Louisiana

  • Tulane Medical Center - New Orleans

Maryland

  • Johns Hopkins University - Baltimore

Massachusetts

  • Fenway Institute - Boston

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2015-08
Est. Completion 2016-11

What the finished NCT02785302 record still lists

NCT02785302 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (69% lower).

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 0 interventions.

NCT02785302 lists 14 locations in 13 states (Florida, California, Colorado).

Frequently Asked Questions

What is clinical trial NCT02785302 about?

NCT02785302 is a clinical study titled "Transitioning HIV+ Adolescents to Adult Care: Exploring Adolescent and Adult Medicine Clinics Role in the Process". This is a multi-site, longitudinal study and it describes the transition process of behaviorally-infected HIV-positive youth as they move from pediatric- and adolescent-specific care to adult care. To achieve this goal, the transition process is characterized from the perspectives of HIV-positive yo...

What is the current status of trial NCT02785302?

This trial is currently completed. The enrollment target is 136 participants. The study started on 2015-08. Estimated completion is 2016-11.

What conditions does trial NCT02785302 study?

This clinical trial studies the following conditions: HIV.

Who is sponsoring clinical trial NCT02785302?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02785302 being conducted?

This trial has 14 study locations across California, Colorado, District of Columbia, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02785302's enrollment target sits among peer trials

136 137th of 303 higher than 167 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02785302, the US trial registry maintained by the National Library of Medicine. NCT02785302 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.